BD Medical oncology

With challenges to achieve efficiencies without compromising patient and healthcare worker safety

Manual process and paper-based systems are often used to transfer patient data and administer treatments

Disconnected department along the pathway: prescription, pharmacy and administration

Medication errors occur during prescription (24.6%)³ preparation (16%)³ and administration (54%)³

Hazardous drugs
12.7 million HCWs are exposed to hazardous drugs in Europe each year⁴

“ONCOLOGY LIVE” WEBINAR SERIES

ONCOLOGY LIVE #1: IV automated compounding during COVID: a European pharmacy perspective

Tuesday, September 29th, 2020 at 4 p.m. GMT

During the webinar, listen as three key opinion leaders from the United Kingdom, Germany and the Netherlands discuss how IV automation has aided them during COVID-19 and the similarities in their respective experiences.
The discussion will also cover findings published in European Journal of Hospital Pharmacy, with an opportunity to engage with the panel.

Anna de Goede
Hospital Pharmacist, Qualified Person for Advanced Therapy Medicinal Products (ATMPs)

Radboud University Medical Center, Nijmegen, Netherlands

Professor Inderjit Singh
Chief Pharmacist

University Hospital Birmingham NHS Foundation Trust, United Kingdom

Professor Irene Krämer
Director of Pharmacy and Professor of Clinical Pharmacy

University Medical Center, Johannes Gutenberg-University, Mainz, Germany

“ONCOLOGY LIVE” WEBINAR SERIES

ONCOLOGY LIVE #1: Intravenous automation in the time of COVID-19: European pharmacies’ perspective

References

World Health Organisation (WHO) Regional Office for Europe. Health topics. Noncommunicable diseases. Cancer Data and Statistics. https://www.euro.who.int/en/health-topics/noncommunicable-diseases/cancer/data-and-statistics
The Cost of Cancer in Europe 2018, European Journal of Cancer, December 2019
Elliot, R et al. Prevalence and Economic Burden of Medication Errors in the NHS in England, Sheffield, 2018
De Raeve P. Preventing the exposure of nurses and health professionals to hazardous drugs. The Parliament Magazine. 2020. https://www.theparliamentmagazine.eu/articles/partner_article/efn/preventingexposurenurses- and-health-professionals-hazardous-drugs Published 20 June 2017. Accessed 13 May 2020
Favier B, Labrosse H, Gilles-Afchain L, et al. The PhaSeal® system: impact of its use on workplace contamination and duration of chemotherapy preparation. J Oncol Pharm Pract. 2012;18(1):37-45.
Terkola R, Czejka M, Berube J. Evaluation of real-time data obtained from gravimetric preparation of antineoplastic agents shows medication errors with possible critical therapeutic impact: Results of a largescale, multicentre, multinational, retrospective study. J Clin Pharm Ther. 2017;42(4):446-453.
Consulting Group Study 2019 – BD Internal Data
Deferred priming and time savings using Microbore primary and secondary infusion set Dec 19 – BD Internal Data
East Tallinn Central Hospital study 2019 – BD Internal Data
Centre for health economics social and health care management. Multi-dimensional evaluation of technological alternatives for the preparation and infusion of chemotherapeutics agents in oncological patients. CIS-HTA Study. Castellanza, Italy: Liuc Business School; 2019.

Our Solutions

European product catalogue

BD Medical oncology

Optimising patient outcomes by providing connected workflows and automating manual processes, while continuing to protect healthcare workers.

Challenges

External factors are creating increasing pressures on oncology services

Increasing demands

3.7 million

Increasing costs

€32 billion

With challenges to achieve efficiencies without compromising patient and healthcare worker safety

Manual process and paper-based systems are often used to transfer patient data and administer treatments

Disconnected department along the pathway: prescription, pharmacy and administration

Medication errors occur during prescription (24.6%)3 preparation (16%)3 and administration (54%)3

Hazardous drugs12.7 million HCWs are exposed to hazardous drugs in Europe each year4

“ONCOLOGY LIVE” WEBINAR SERIES

ONCOLOGY LIVE #1: IV automated compounding during COVID: a European pharmacy perspective

Transforming the oncology pathway

Protecting HCWs by reducing the risk of exposure

Connecting workflows to minimise safety failures

Automating manual processes to increase efficiency

Patient

Oncologist

With complex clinical decision processes and more and more individualised chemotherapy to prescribe for your patients, BD solutions can help you to reduce the risk of prescribing errors.

Drug prescription

Venous access

Pharmacist

Each day you are making up many individually tailored prescriptions. Deploying BD Oncology solutions can help you to reduce medication preparation errors and improve the efficiency within your pharmacy.

Order verification

Drug preparation

Gravimetric analysis

Drug verification

Hazardous drugs monitoring

Nurse

For you and your patients, safely administering the chemotherapy is key. BD solutions help to reduce drug administration errors, improve efficiency and support your safety as well as that of your patients.

Patient preparation

Patient assessment

Pump programming

“ONCOLOGY LIVE” WEBINAR SERIES

ONCOLOGY LIVE #1: Intravenous automation in the time of COVID-19: European pharmacies’ perspective

References

Solution

BD Cato™ Prescribe reduces the risk of prescribing errors and supports effective treatment decisions. The benefits of BD Cato™ Prescribe include:

Impact areas

Solution

Safe chemotherapy relies on safe vascular access.

BD offers a range of vascular access devices (VADs) which help optimise the clinical experience for patients and healthcare professionals.

Impact areas

Solution

Once verified by the pharmacist, the prescription is sent to BD Cato™ Pharmacy. The risk of medication errors is reduced by BD cameras, barcode scanners and gravimetric scale which:

Impact areas

Solution

BD helps reduce the risk of direct exposure to hazardous drugs during 2 crucial steps:

Impact areas

Solution

Gravimetric technology contributes to patient safety by detecting 7.86% more errors.6

Once the drug is scanned, gravimetric analysis is performed to verify its content.

Impact areas

Solution

The pharmacist verifies the medication is correct and labels it with a barcode. BD Cato™ Medication Workflow Solutions assists quality assurance by using guided gravimetric, barcoded, and paperless technology which helps:

Impact areas

Solution

Between the pharmacy and the treatment centre, safe handling of hazardous drugs relies on comprehensive internal monitoring procedures.

BD® HD Check is a handheld device which detects contamination in less than 10 minutes, improving healthcare worker safety.*

Impact areas

Solution

The nurse prepares the patient for administration of chemotherapy. Using the BD PhaSeal™ Closed-System Transfer Device, BD MicroBore Secondary Sets and BD Vascular Access Devices,

Impact areas

Solution

The BD Cato™ ReadyMed App ensures the right drug goes to the right patient.

The App is easy to use and requires fewer steps than a typical patient assessment:

Impact areas

Solution

The BD BodyGuard™ Duo has two independent infusion channels that provide a true concurrent flow capability. Its single user interface offers flexibility and convenience by freeing up nurse time for even the most complex infusions.

Combining the BD MicroBore Secondary Set, BD PhaSeal™ Closed-System Transfer Device and BD Cato™ Pharmacy can save up to 39% of clinical time and help reduce error.10

Ultimately BD systems reduce medication error, improve workflow efficiency, and reduce the risk of complications.

Impact areas

Company

Support

Contact Support

Medication errors occur during prescription (24.6%)³ preparation (16%)³ and administration (54%)³

Hazardous drugs
12.7 million HCWs are exposed to hazardous drugs in Europe each year⁴

BD Cato^™ Prescribe reduces the risk of prescribing errors and supports effective treatment decisions. The benefits of BD Cato^™ Prescribe include:

Once verified by the pharmacist, the prescription is sent to BD Cato^™ Pharmacy. The risk of medication errors is reduced by BD cameras, barcode scanners and gravimetric scale which:

Gravimetric technology contributes to patient safety by detecting 7.86% more errors.⁶

The pharmacist verifies the medication is correct and labels it with a barcode. BD Cato^™ Medication Workflow Solutions assists quality assurance by using guided gravimetric, barcoded, and paperless technology which helps:

BD^® HD Check is a handheld device which detects contamination in less than 10 minutes, improving healthcare worker safety.^*

The nurse prepares the patient for administration of chemotherapy. Using the BD PhaSeal^™ Closed-System Transfer Device, BD MicroBore Secondary Sets and BD Vascular Access Devices,

The BD Cato^™ ReadyMed App ensures the right drug goes to the right patient.

The BD BodyGuard^™ Duo has two independent infusion channels that provide a true concurrent flow capability. Its single user interface offers flexibility and convenience by freeing up nurse time for even the most complex infusions.

Combining the BD MicroBore Secondary Set, BD PhaSeal^™ Closed-System Transfer Device and BD Cato^™ Pharmacy can save up to 39% of clinical time and help reduce error.¹⁰